Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1835 of 6351
-
Experimental combo aims to boost immune attack on tough lung cancers
Disease control OngoingThis study is open to adults with small cell lung cancer and other neuroendocrine tumours that are positive for the tumour marker Delta-like 3 (DLL3). The study is in people with advanced cancer for whom previous treatment was not successful or no standard treatment exists. The …
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Smart algorithm aims to tailor blood thinner use after stents
Disease control Recruiting nowThe use of aspirin combined with a P2Y12 inhibitor (dual antiplatelet therapy, DAPT) represents the standard of care for patients undergoing percutaneous coronary intervention (PCI) with stent implantation. The TAILOR-DAPT trial aims to investigate the benefits of a score-based d…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 26, 2026 17:59 UTC
-
New drip combo aims to stop chemo nausea in kids
Symptom relief CompletedChemotherapy-induced nausea and vomiting are serious side effects of cancer treatment that can have a significant negative impact on a patient's quality of life. Although the prevalence of nausea and vomiting has significantly decreased due to the implementation of new antiemetic…
Phase 3 • Sponsor: Immune Oncology Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Real-World test: can a targeted drug keep PNH in check for years?
Disease control OngoingThis is a 36-month, long-term, multicenter, observational study designed to describe the real world effectiveness of pegcetacoplan in patients with PNH. Patients meeting the eligibility criteria will be enrolled in the study and followed prospectively for approximately 36 months.…
Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New shot Mim8 shows promise for hemophilia a bleed control
Disease control CompletedThis study is looking at how safe it is to switch from emicizumab to Mim8, in people with haemophilia A. Mim8 is a new medicine that is used to prevent bleeding episodes in people with haemophilia A. Mim8 works by replacing the function of the missing clotting factor VIII (FVIII)…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Shockwave therapy opens hardened arteries for Life-Saving aortic repair
Disease control Recruiting nowThe study will evaluate, in a controlled setting, the efficacy and safety of the intravascular lithotripsy using Shockwave™ M5+/L6 Peripheral Intravascular Lithotripsy Catheter to facilitate delivery of aortic large-bore devices in iliac calcified access.
Sponsor: EndoCore Lab s.r.l. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pacing technique could boost heart function in mild failure
Disease control OngoingThis is a two-center, prospective randomized controlled trial. The aim of this study is to compare the clinical efficacy of early left bundle branch pacing for cardiac resynchronization therapy and guideline-directed medical therapy in heart failure with mild-reduced ejection fra…
Sponsor: Fu Wai Hospital, Beijing, China • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo aims to tackle aggressive brain tumors that have come back
Disease control Recruiting nowGlioblastoma (GBM), WHO grade IV glioma, represents the majority of adult malignant primary brain tumors, with an incidence of 2-3 per 100,000 person-years. The survival for GBM has increased in the last decade but is still low with a median survival of 15-18 months. Recurrence a…
Phase 1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New program aims to boost HIV care and safety for black women facing abuse
Disease control Recruiting nowThis study tests a 5-session cognitive behavioral approach program (herein referred to as the 1MoreStep intervention) to train Black women living with HIV (BWLWHI) and exposed to intimate partner violence (IPV) in the past 2 years (hereafter, BWLWHI) in: 1) cognitive and behavior…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Promising drug trial for kids with rare Muscle-Weakening disease
Disease control OngoingThe primary purpose of this study is to characterize the pharmacokinetics and pharmacodynamics of treatment with ravulizumab intravenous infusion in pediatric participants with gMG.
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Sound waves may stop stubborn seizures in ICU patients
Symptom relief Recruiting nowIn this study, the investigators propose Pulsed Low-Intensity Focused Ultrasound (PLIFU) stimulation of brain regions that modulate (thalamus) or generate focal motor seizures (primary motor cortex), with the goal of ameliorating seizure activity in subjects in non-convulsive or …
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Tailored support for seniors may speed recovery after CAR-T cancer treatment
Symptom relief Recruiting nowThis clinical trial compares the effectiveness of geriatric assessment (GA) guided interventions to accelerate functional recovery after chimeric antigen receptor T-cell (CAR-T) therapy compared to standard of care (SOC) in patients 60 years and older with B-cell non-Hodgkin lymp…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Could a heart pill beat long COVID fatigue? new trial aims to find out.
Symptom relief OngoingThe goal of this clinical trial is to evaluate the therapeutic value of an approved drug (Vericiguat) in patients with post-COVID-19 syndrome, who suffer from profound tiredness or fatigue, regardless of bed rest.The main questions it aims to answer are: • Does Vericiguat relieve…
Phase 2 • Sponsor: Charite University, Berlin, Germany • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Weight loss classes added to cardiac rehab may ease AFib symptoms
Symptom relief OngoingOne-in-four Canadians will be diagnosed with an abnormal heart rhythm called atrial fibrillation (AF) in their lifetime. This is expected to double by 2050, owing to an aging population and increased age- and health behaviour-associated AF risk factors (e.g., poor cardiorespirato…
Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
FLASH radiotherapy: a Blink-and-You'll-Miss-It cancer treatment?
Disease control OngoingThis is a single center randomized selected Phase II study of FLASH radiotherapy (RT) versus standard of care (SOC) radiotherapy in patients with localized Cutaneous Squamous Cell Carcinoma (cSCC) or Basal Cell Carcinoma (BCC). In summary, the aims of the study are to describe a…
Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for advanced skin cancer: targeted pill tested in china
Disease control CompletedThis is a Phase IV, single arm, multicenter study designed to evaluate the efficacy and safety profile of Sonidegib in chinese participants with locally advanced basal cell carcinoma (laBCC) who are not amenable to radiation therapy, curative surgery or other local therapies.
Phase 4 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
VA launches major trial of THC and CBD for Veterans' nerve pain
Symptom relief Recruiting nowChronic neuropathic pain (CNP) is disabling. Research on frontline treatments for CNP, shows inconsistent outcomes and dissatisfaction among Veterans. Veterans and clinicians have shown significant interest in cannabis derivatives (THC, CBD) for neuropathic pain control, but ther…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New combo treatment shows promise for kids with rare bone marrow failure
Disease control CompletedThe aim of this study was to investigate the safety, tolerability, and effectiveness of eltrombopag in combination with immunosuppressive therapy (IST) in real world practice in pediatric patients with severe aplastic anemia (sAA) in Korea. The study used data over a 6-month peri…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New eye injection aims to halt vision loss in dry AMD
Disease control OngoingThe Phase 1 safety study of VOY-101 is comprised of escalating dose Cohorts, followed by a Phase 2 at the recommended phase 2 dose.
Phase 1/2 • Sponsor: Perceive Biotherapeutics, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat lung cancer
Disease control Recruiting nowThis is a phase 1, single-center, open-label study that enrolls adult subjects with extensive stage lung cancer or stage IV non-small cell lung cancer that is platinum-refractory and received PD-1 and/or PD-L1 therapy. The purpose of this study is to test the safety of using a ne…
Early phase 1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC